B3GALT4 and breast carcinoma: In this study, we validated the presence of GM1 on sEV derived from breast cancer cells, and explored the mechanism underlying the increased sEV secretion in B3GALT4-overexpressed cells and the vesicular GM1 induced EMT process in recipient cells by proteomic analysis.